Matthew McManus Power - 01 Feb 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
President - Diag & Spatial Bio
Issuer ticker
TECH
Reported as of
01 Feb 2026
Net transaction value
-$106,710
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Feb 2026, 17:04:06 UTC
Prior SEC filing
19 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.

Key filing fact

Matthew McManus Power filed Form 4 for BIO-TECHNE Corp (TECH) on 03 Feb 2026.

Key facts

  • This page summarizes Matthew McManus Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 03 Feb 2026, 17:04.

Change

  • Previous filing in this sequence was filed on 19 Aug 2025.
  • Current net transaction value: -$106,710.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001908268 Primary reporting owner

McManus Matthew

Relationship
President - Diag & Spatial Bio
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Signature date
03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+4,621
Change %
+98%
Price
$0.000000
Shares after
9,356
Date
01 Feb 2026
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
$106,710
Shares
-1,665
Change %
-18%
Price
$64.09
Shares after
7,691
Date
01 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,621
Change %
-50%
Price
$0.000000
Shares after
4,620
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,621
Exercise price
Footnotes
F1, F3
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,888
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,888
Exercise price
Footnotes
F1, F2
TECH holding Derivative

Performance Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,951
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,951
Exercise price
$68.54
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,902
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,902
Exercise price
$68.54
Footnotes
F4
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,825
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,825
Exercise price
Footnotes
F1, F5
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,275
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,275
Exercise price
Footnotes
F1, F6
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,320
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,320
Exercise price
$74.91
Footnotes
F7
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,243
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,243
Exercise price
Footnotes
F1, F8
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,622
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,622
Exercise price
Footnotes
F1, F9
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,614
Date
01 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,614
Exercise price
$53.60
Footnotes
F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F2

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F3

4,621 restricted stock units vest on 2/1/2026 and 4,620 restricted stock units vest on 2/1/2027.

Footnote F4

Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.

Footnote F5

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F6

2,637 restricted stock units vest on 8/15/2026 and 2,638 restricted stock units vest on 8/15/2027.

Footnote F7

Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F8

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F9

3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.

Footnote F10

Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .